Confirm the intended product
A shared active ingredient can appear across products with different labeling, uses, strengths, and market status.
Active ingredient comparison
Nintedanib brands and price references.
Nintedanib appears in 2 brand or manufacturer-labeled product profiles in the US Med Access catalog, covering 5 package references. Listed EU figures currently range from €2,609.13 to €3,990.89, while captured U.S. cash references range from $13,474.78 to $13,474.78. Product names, dosage forms, strengths, indications, and packages must be reviewed before treating any figures as comparable.
Brand profiles2
Package references5
EU references from€2,609.13
Last reviewed
Multi-brand ingredient index
Nintedanib listed products
These profiles share a named active ingredient, but that does not establish therapeutic interchangeability, equivalent approval, or an admissible route. Compare the exact product and package.
| Brand or product | Category | Packages | EU ref. from | U.S. cash ref. from | Profile |
|---|---|---|---|---|---|
| OfevBoehringer Ingelheim Pharma GmbH & Co.KG | Oncology | 2 | €3,493.82 | $13,474.78 | Open profile → |
| VARGATEFBoehringer Ingelheim Pharma GmbH & Co.KG | Specialty Care | 3 | €2,609.13 | $13,474.78 | Open profile → |
How to use this page
Compare identity before price.
Open each linked product profile and match the intended brand, manufacturer, strength, dosage form, and package quantity. Normalize price only after the products are meaningfully comparable.
Normalize the package
Compare equivalent quantities and keep the original package description visible beside any unit-level math.
Request a current review
Price, availability, exchange rates, source status, and route requirements can change after publication.
Product-specific review
Need a Nintedanib package comparison?
Share the intended brand, strength, dosage form, quantity, destination, and organization type. No substitution, supply, or import outcome is guaranteed.